Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database.

Zhao, Hui; Li, Jun-Min; Li, Zi-Ran; Zhang, Qian; Zhong, Ming-Kang; Yan, Ming-Ming; Qiu, Xiao-Yan

Zhao, Hui; Li, Jun-Min; Li, Zi-Ran; Zhang, Qian; Zhong, Ming-Kang; Yan, Ming-Ming; Qiu, Xiao-Yan.

Afiliação

Zhao H; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
Li JM; School of Pharmacy, Fudan University, Shanghai, China.
Li ZR; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
Zhang Q; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
Zhong MK; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
Yan MM; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
Qiu XY; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.

Front Pharmacol ; 14: 1182113, 2023.

Article em En | MEDLINE | ID: mdl-37502210

Palavras-chave

FAERS; MACE; TT; major adverse cardiovascular events; pharmacovigilance; testosterone treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google